ArticleMedical oncology (Northwood, London, England)2025

Isoliquiritigenin attenuates tumor progression and PD-L1 expression by inhibiting the phosphorylation of STAT3 in melanoma.

Haiyan Zeng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.